We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$485M
AUM Growth
+$29.1M
Cap. Flow
-$15.4M
Cap. Flow %
-3.18%
Top 10 Hldgs %
51.57%
Holding
81
New
1
Increased
35
Reduced
19
Closed
10

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.15%
2 Healthcare 21.39%
3 Financials 12.53%
4 Real Estate 9.47%
5 Communication Services 7.93%

Similar funds

Newtyn Management's Q4 2022 Portfolio in Review

As of Q4 2022, Newtyn Management held 81 positions worth $485M, up 6.4% from $455M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Newtyn Management withdrew a net $15.4M in Q4 2022, closing 10 positions and reducing 19 holdings. Its most notable exit was Sylvamo, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Newtyn Management opened a new position in EUDA Health Holdings worth $33.4K.

  • Newtyn Management's largest Q4 2022 buy was EUDA Health Holdings: 1,000 shares worth $33.4K.
  • Newtyn Management added most to People Inc in Q4 2022, an estimated $20.7M increase.
  • Newtyn Management's biggest Q4 2022 reduction was Theravance Biopharma, cutting an estimated $11M.
  • Newtyn Management fully exited Sylvamo in Q4 2022, selling an estimated $14.9M.
  • Newtyn Management's ten largest holdings make up 52% of its $485M portfolio in Q4 2022.
  • Newtyn Management opened 1 new position and closed 10 in Q4 2022.
  • Newtyn Management's portfolio value rose 6.4% quarter-over-quarter to $485M.

Based on Newtyn Management's 13F filing for Q4 2022, filed 14 Feb 2023.